
9.22 Delayed Data As of Jan 27 | ![]() Today’s Change | 5.71 Today|||52-Week Range 13.34 | +8.47% Year-to-Date |
New Strong Sell Stocks for January 13th (Revised) Jan 16 / Zacks.com - Paid Partner Content |
Previous close | 9.22 |
Today’s open | 9.18 |
Day’s range | 9.16 - 9.24 |
Volume | 8,085 |
Average volume (3 months) | 1,317,286 |
Market cap | $2.4B |
Earnings growth (last year) | -69.23% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | +52.70% |
Revenue growth (last year) | -4.22% |
P/E ratio | 84.8 |
Price/Sales | 1.31 |
Price/Book | 0.90 |
Today’s change | Today’s % change | |
---|---|---|
XENEXenon Pharmaceutical... | -0.53 | -1.39% |
---- | ||
AKROAkero Therapeutics I... | 0.00 | 0.00% |
---- |
Next reporting date | March 2, 2023 |
EPS forecast (this quarter) | $0.24 |
Annual revenue (last year) | $5.8B |
Annual profit (last year) | $216.1M |
Net profit margin | 3.71% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Barcelona, Catalonia |